These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 22068461

  • 1. Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
    Jardemark K, Marcus MM, Malmerfelt A, Shahid M, Svensson TH.
    Psychopharmacology (Berl); 2012 May; 221(1):115-31. PubMed ID: 22068461
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
    Konradsson A, Marcus MM, Hertel P, Svensson TH, Jardemark KE.
    Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
    [Abstract] [Full Text] [Related]

  • 3. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
    Jardemark KE, Liang X, Arvanov V, Wang RY.
    Neuroscience; 2000 Aug; 100(1):1-9. PubMed ID: 10996453
    [Abstract] [Full Text] [Related]

  • 4. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
    Marcus MM, Wiker C, Frånberg O, Konradsson-Geuken A, Langlois X, Jardemark K, Svensson TH.
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):891-903. PubMed ID: 19835668
    [Abstract] [Full Text] [Related]

  • 5. Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.
    Marcus MM, Jardemark K, Malmerfelt A, Björkholm C, Svensson TH.
    Neuropsychopharmacology; 2010 Aug; 35(9):1952-61. PubMed ID: 20463659
    [Abstract] [Full Text] [Related]

  • 6. Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.
    Olsen CK, Kreilgaard M, Didriksen M.
    Pharmacol Biochem Behav; 2006 Jun; 84(2):259-65. PubMed ID: 16782180
    [Abstract] [Full Text] [Related]

  • 7. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ, Muhlhauser M, Zhai J, Yang CR, Nisenbaum ES.
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex.
    Ninan I, Jardemark KE, Wang RY.
    Neuropharmacology; 2003 Mar; 44(4):462-72. PubMed ID: 12646283
    [Abstract] [Full Text] [Related]

  • 9. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
    Amargós-Bosch M, Adell A, Artigas F.
    J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545
    [Abstract] [Full Text] [Related]

  • 10. Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
    Björkholm C, Frånberg O, Malmerfelt A, Marcus MM, Konradsson-Geuken Å, Schilström B, Jardemark K, Svensson TH.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(3):. PubMed ID: 25522408
    [Abstract] [Full Text] [Related]

  • 11. Biphasic modulation of NMDA-induced responses in pyramidal cells of the medial prefrontal cortex by Y-931, a potential atypical antipsychotic drug.
    Jardemark KE, Ai J, Ninan I, Wang RY.
    Synapse; 2001 Sep 15; 41(4):294-300. PubMed ID: 11494400
    [Abstract] [Full Text] [Related]

  • 12. Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat.
    Björkholm C, Jardemark K, Schilström B, Svensson TH.
    Eur Neuropsychopharmacol; 2015 Oct 15; 25(10):1842-7. PubMed ID: 26233606
    [Abstract] [Full Text] [Related]

  • 13. Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.
    Marcus MM, Jardemark K, Malmerfelt A, Gertow J, Konradsson-Geuken A, Svensson TH.
    Synapse; 2012 Apr 15; 66(4):277-90. PubMed ID: 22121030
    [Abstract] [Full Text] [Related]

  • 14. Alterations in brain extracellular dopamine and glycine levels following combined administration of the glycine transporter type-1 inhibitor Org-24461 and risperidone.
    Nagy K, Marko B, Zsilla G, Matyus P, Pallagi K, Szabo G, Juranyi Z, Barkoczy J, Levay G, Harsing LG.
    Neurochem Res; 2010 Dec 15; 35(12):2096-106. PubMed ID: 20725779
    [Abstract] [Full Text] [Related]

  • 15. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
    Arvanov VL, Wang RY.
    Neuropsychopharmacology; 1998 Mar 15; 18(3):197-209. PubMed ID: 9471117
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of atypical and typical antipsychotic drugs on N-methyl-D-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex.
    Ninan I, Jardemark KE, Wang RY.
    Synapse; 2003 May 15; 48(2):66-79. PubMed ID: 12619040
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.
    Tarazi FI, Moran-Gates T, Gardner MP, Graulich A, Lamy C, Liégeois JF.
    J Mol Neurosci; 2007 May 15; 32(3):192-8. PubMed ID: 17873364
    [Abstract] [Full Text] [Related]

  • 18. Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs.
    Fumagalli F, Frasca A, Racagni G, Riva MA.
    Mol Pharmacol; 2008 May 15; 73(5):1484-90. PubMed ID: 18250147
    [Abstract] [Full Text] [Related]

  • 19. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
    Ugale RR, Hirani K, Morelli M, Chopde CT.
    Neuropsychopharmacology; 2004 Sep 15; 29(9):1597-609. PubMed ID: 15100702
    [Abstract] [Full Text] [Related]

  • 20. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.
    López-Gil X, Babot Z, Amargós-Bosch M, Suñol C, Artigas F, Adell A.
    Neuropsychopharmacology; 2007 Oct 15; 32(10):2087-97. PubMed ID: 17356574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.